Corante

About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
Kilomentor
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
ChemBark
Realizations in Biostatistics
Chemjobber
Pharmalot
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Business|Bytes|Genes|Molecules
Eye on FDA
Chemical Forums
Depth-First
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net


Medical Blogs
DB's Medical Rants
Science-Based Medicine
GruntDoc
Respectful Insolence
Diabetes Mine


Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem


Politics / Current Events
Virginia Postrel
Instapundit
Belmont Club
Mickey Kaus


Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Open-Source Pharmaceutical Babble | Main | Let's Just Spread This Deal Out All Over the Paper, Why Don't We? »

July 29, 2010

New from OSI / Astellas

Email This Entry

Posted by Derek

When last we heard about the takeover of OSI by Astellas, everyone was standing around wondering what was going to happen. Some of that uncertainly seems, unfortunately, to be vanishing. A source tells me that the OSI people have been informed that their Ardsley headquarters and the Melville site on Long Island are to close. The fate of the Farmingdale site on LI is still unclear. Ardsley used to be where Purdue Pharma had a lot of people, and I don't think that OSI has been there that long, actually.

I've also heard that development staff at OSI have been told that they're being let go, but are free to re-apply to Astellas - that could mean several things, none of them particularly good, but that's all I have so far.

Comments (7) + TrackBacks (0) | Category: Business and Markets


COMMENTS

1. Hap on July 29, 2010 11:35 AM writes...

Wow. The "you can reapply for your old job" bit is always endearing, like Satan Jr. practicing his moves before he moves up to the top spot. I hope there's a warm spot somewhere for the HR people who came up with that idea.

Why don't they ever do that with board members or CEOs?

Permalink to Comment

2. petros on July 29, 2010 1:47 PM writes...

What about the UK site (OSI (prosidion))?

Permalink to Comment

3. Ed on July 29, 2010 2:27 PM writes...

"WE'RE DOOMED!"

Permalink to Comment

4. Chemaniac on August 2, 2010 7:16 AM writes...

Well, it's official now. From the FiercePharma site:

http://www.fiercepharma.com/story/astellas-shutter-n-y-facilities-cut-jobs/2010-07-30

Permalink to Comment

5. Anonymous on August 4, 2010 8:59 PM writes...

I'm surprised Roche didn't step in an kick Astellas to the curb. Hey, OSI has tarceva and others including a glucokinase activator that appears to be progressing. Remember where glucokinase activators originated??

Permalink to Comment

6. Winfred Rajaratnam on January 7, 2013 1:51 PM writes...

I consider something really special in this site.

Permalink to Comment

7. Rod Byers on January 7, 2013 4:29 PM writes...

I'm still learning from you, as I'm trying to achieve my goals. I certainly liked reading everything that is written on your blog.Keep the stories coming. I loved it!

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
A Last Summer Day Off
The Early FDA
Drug Repurposing
The Smallest Drugs
Life Is Too Short For Some Journal Feeds
A New Look at Phenotypic Screening
Small Molecules - Really, Really Small
InterMune Bought